Cardiac Ablation Insurance Denied? How to Appeal

Cardiac ablation is a minimally invasive procedure that uses energy — radiofrequency or cryotherapy — to destroy abnormal electrical pathways in the heart causing arrhythmias such as atrial fibrillation (AFib), supraventricular tachycardia (SVT), atrial flutter, and ventricular tachycardia (VT). It is guideline-endorsed by the ACC, AHA, and Heart Rhythm Society (HRS), yet insurance companies regularly deny coverage, citing inadequate antiarrhythmic drug trials, experimental classification, or insufficient documentation of medical necessity.

If your cardiac ablation was denied, here is how to fight back.

Why Insurers Deny Cardiac Ablation

Insufficient antiarrhythmic drug (AAD) trials. Most insurer policies require documented failure of at least one — and often two — antiarrhythmic medications (Class I or III agents such as flecainide, propafenone, sotalol, or amiodarone) before approving ablation. If your records do not clearly document prior drug trials, doses, duration, and reason for failure (ineffectiveness or intolerance), the claim will be denied.

Experimental classification for specific ablation types. Standard pulmonary vein isolation (PVI) for AFib is broadly covered, but newer techniques such as pulsed-field ablation (PFA) or ablation for long-standing persistent AFib may still be classified as investigational by some insurers despite growing evidence.

Paroxysmal vs. persistent vs. long-standing persistent AFib. Coverage policies often differentiate by AFib type. Some insurers limit first-line ablation coverage to paroxysmal AFib while requiring extensive drug failure documentation for persistent or long-standing persistent AFib.

Ventricular tachycardia ablation. VT ablation, particularly in patients with structural heart disease, may be denied if the insurer does not recognize it as standard of care or if prior ICD therapy documentation is insufficient.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization issues. Ablation almost always requires pre-authorization. Authorization obtained for one arrhythmia type (e.g., SVT) may not cover ablation for a different indication (e.g., AFib) discovered intraoperatively.

Asymptomatic arrhythmia. Some policies require documented symptoms (palpitations, syncope, reduced exercise tolerance, heart failure exacerbation) linked to the arrhythmia. Asymptomatic AFib detected incidentally may face denial without documented clinical impact.

CPT Codes for Cardiac Ablation

• CPT 93653 — Comprehensive electrophysiologic evaluation with right atrial pacing/recording, His bundle recording, right ventricular pacing/recording, and ablation of arrhythmia focus; supraventricular tachycardia
• CPT 93654 — Same as above; ventricular tachycardia
• CPT 93656 — Comprehensive EP evaluation including transseptal catheterization and ablation for treatment of supraventricular arrhythmia by pulmonary vein isolation
• CPT 93657 — Additional pulmonary vein(s) isolation (add-on to 93656)
• CPT 93655 — Intracardiac catheter ablation of a discrete mechanism of arrhythmia (add-on)
• CPT 93660 — Evaluation of cardiovascular function with tilt table evaluation

What Documentation Proves Medical Necessity

Electrophysiology (EP) study findings. The EP study report documenting the inducible arrhythmia, mapping of the arrhythmia circuit, and mechanism of the targeted ablation is the core clinical record for your appeal.

Holter monitor and event recorder data. Continuous cardiac monitoring records (CPT 93241–93248) demonstrating arrhythmia burden, correlation with symptoms, and frequency of episodes are critical for demonstrating clinical significance.

Antiarrhythmic drug trial documentation. Medical records showing each drug tried, dose, duration (typically at least 4–6 weeks unless dose-limited intolerance), and documented failure — whether breakthrough arrhythmia, adverse effects, or patient intolerance — are essential. This is the most common documentation gap that causes denials.

Echocardiography findings. Structural heart evaluation showing left atrial size, ejection fraction, and valvular function establishes baseline cardiac anatomy and helps justify rhythm control strategy.

Electrophysiologist's letter of medical necessity. Should cite the 2023 ACC/AHA/ACCP/HRS Guideline for Diagnosis and Management of Atrial Fibrillation (or relevant HRS/EHRA/ECAS expert consensus statement for VT ablation). For AFib ablation, the CABANA trial demonstrated improved quality of life and reduced arrhythmia recurrence with ablation vs. drug therapy.

Symptom documentation. Clinic notes documenting symptoms, functional limitation (NYHA class, exercise intolerance), or quality-of-life impact strengthen the medical necessity argument.

How to Appeal a Cardiac Ablation Denial

Step 1: Identify the specific denial reason. Request the full EOB)" class="auto-link">Explanation of Benefits and the insurer's published coverage policy for cardiac ablation. Policies vary significantly — some require one AAD failure, others two. Know exactly what criteria you need to meet.

Step 2: File a formal internal appeal. Include a complete medical record package: EP study report, monitoring data, AAD trial documentation, echocardiogram, and your electrophysiologist's letter. Reference the ACC/AHA/HRS guidelines explicitly in the appeal letter.

Step 3: Peer-to-peer review with your electrophysiologist. Request that the insurer's reviewing physician be a cardiac electrophysiologist, not a general internist. An EP specialist is far more likely to recognize the clinical necessity when discussing mechanism, arrhythmia burden, and drug failure with your treating physician.

Step 4: First-line ablation argument. For paroxysmal AFib in particular, the 2023 ACC/AHA guideline now supports catheter ablation as a reasonable first-line option (Class IIa) without mandatory prior AAD failure for symptomatic patients. If your insurer's policy has not been updated to reflect this, cite the guideline directly in your appeal.

Step 5: External independent review. After internal appeal exhaustion, request an Independent Medical Review. External reviewers regularly overturn cardiac ablation denials, particularly when the denial is based on outdated coverage policies that contradict current cardiology guidelines.

Step 6: State insurance commissioner complaint. If your insurer's policy does not align with published clinical guidelines, filing a complaint can prompt regulatory review of the coverage criteria.

Special Situations: Ablation After ICD Shocks

Patients with implantable cardioverter-defibrillators (ICDs) who experience recurrent VT triggering device shocks have a particularly strong medical necessity argument for VT ablation. The VANISH and SMASH-VT trials demonstrated improved outcomes with ablation in ICD patients with recurrent VT. Document the number of ICD therapies, shock burden, and any escalation of antiarrhythmic therapy — this establishes both failed drug therapy and urgency.

Fight Back With ClaimBack

Cardiac ablation denials are frequently based on incomplete documentation review or outdated coverage policies. With the right clinical evidence and guideline citations, these decisions can be reversed. ClaimBack helps you structure a professional, complete appeal letter tailored to your specific arrhythmia and denial reason.

Start your appeal at ClaimBack and get back in rhythm.

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs. External Insurance Appeal: What's the Difference?
• Common Reasons Insurance Claims Are Denied